GlassScriptPhysician profile
Erik Van Ginkel
NPI 1649352816
$811.68
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $96.32 · 2021: $59.66.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $200.34 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $124.99 | 2019 | |
| Daiichi Sankyo INC. | $69.65 | 2019 | |
| Pfizer INC. | $58.43 | 2019 | |
| Janssen Biotech, INC. | $56.40 | 2019-2020 | |
| Amgen INC. | $52.13 | 2019 | |
| Scilex Pharmaceuticals INC. | $32.51 | 2019 | |
| West Therapeutics Development, LLC | $23.61 | 2021 | |
| Viiv Healthcare Company | $23.10 | 2019 | |
| Glaxosmithkline, LLC. | $22.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $20.33 | 2021 | |
| Novo Nordisk INC | $17.99 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.52 | 2019 | |
| Collegium Pharmaceutical, INC. | $16.97 | 2019 | |
| Abbvie INC. | $16.33 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $16.31 | 2020 | |
| Amarin Pharma, INC. | $15.72 | 2021 | |
| Kaleo, INC. | $13.70 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.25 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Van Ginkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.